RERG antibody
Principal name
RERG antibody
Alternative names for RERG antibody
Ras-related and estrogen-regulated growth inhibitor
Ncbi ID
9606, NP_001177655, NM_001190726, NP_116307, NP_001157684.1, NM_181988, NM_001164212, NM_001164214, NM_032918
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB), Enzyme Immunoassay (E)
Background of RERG antibody
- Kit Component:
- - KN314672G1, Rerg gRNA vector 1 in pCas-Guide vector
- KN314672G2, Rerg gRNA vector 2 in pCas-Guide vector
- KN314672D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Woodfield GW., et al. (2007) Cancer Res. 67(18):8439-43.
Finlin BS., et al. (2001) J Biol Chem. 276(45):42259-67.
Immunofluorescence of purified MaxPab antibody to RERG on HeLa cell. [antibody concentration 10 ug/ml]
Western Blot analysis of RERG expression in transfected 293T cell line (H00085004-T01) by RERG MaxPab polyclonal antibody.Lane 1: RERG transfected lysate(21.89 KDa).Lane 2: Non-transfected lysate.
Human COLO205; WB Suggested Anti-RERG Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:1562500. Positive Control: COLO205 cell lysate; RERG antibody - C-terminal region (ARP59687_P050) in Human COLO205 cells using Western Blot
Rat Lung; WB Suggested Anti-Rerg Antibody. . Titration: 1.0 ug/ml. . Positive Control: Rat Lung; Rerg antibody - middle region (ARP59688_P050) in Rat Lung cells using Western Blot
Recombinant human RERG, 1-199 aa, His-tagged
WB Suggested Anti-RERG Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:1562500; Positive Control: COLO205 cell lysate
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA342693 | RERG antibody |
||||||
| Rabbit Polyclonal Anti-RERG Antibody | |||||||
 |
Rabbit | IgG | Purified | Bov, Can, Eq, GP, Gt, Hu, Ms, Por, Rb, Rt, Ye, Ze | WB |
50 µg /
€360.00
|
|
| OriGene Technologies, Inc. | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP303564 | RERG |
||||
| Recombinant protein of human RAS-like, estrogen-regulated, growth inhibitor (RERG) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€680.00
|
|
| OriGene Technologies, Inc. | |||||
| AR09861PU-L | RERG (1-199, His-tag) |
||||
 |
Human | Purified | > 85 % | E. coli |
0.25 mg /
€1,000.00
|
| OriGene Technologies GmbH | |||||
 +1 additional image |
|||||
| AR09861PU-N | RERG (1-199, His-tag) |
||||
|
Human | Purified | > 85 % | E. coli |
50 µg /
€370.00
|
| OriGene Technologies GmbH | |||||
| +1 additional image |
|||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY434024 | RERG overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC203564L2V | Lenti ORF particles, RERG (mGFP-tagged) - Human RAS-like, estrogen-regulated, growth inhibitor (RERG), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€907.00
|
|
| OriGene Technologies, Inc. | ||
| RC203564L1V | Lenti ORF particles, RERG (Myc-DDK tagged) - Human RAS-like, estrogen-regulated, growth inhibitor (RERG), transcript variant 1 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€804.00
|
|
| OriGene Technologies, Inc. | ||
